Abstract
Aim:
To investigate the effects of a tissue-specific selective estrogen receptor modulator, idoxifene, on hepatic fibrosis in rats.
Methods:
Hepatic fibrosis was induced by dimethylnitrosamine (DMN) in male rats. The DMN model of hepatic fibrosis and the hepatocytes undergoing oxidative stress were treated with idoxifene respectively. The effect of idoxifene on hepatic fibrosis in the DMN model was examined by immunohistochemistry. Effects of idoxifene on antioxidant enzyme levels of copper, zinc-dependent superoxide dismutase (CuZn-SOD), and cellular glutathione peroxidase (GSHPx) were measured by ELISA. Effects of idoxifene on activation, proliferation, and apoptosis of culture-activated hepatic stellate cells (HSC) were analysed by immunohistochemistry, bromodeoxyuridine (BrdU) uptake, and flow cytometry, respectively.
Results:
Idoxifene could markedly suppress DMN-induced hepatic fibrosis in male rats. A treatment of 0.4mg·kg-1·d-1 of idoxifene reduced the protein levels of collagen in the DMN model by 41.19% (P<0.05). Protein level of CuZn-SOD and activitiy of GSHPx in liver treated with DMN plus 0.4 mg·kg-1·d-1 of idoxifene were 2.65 times (P<0.05) and 1. 2.08 times greater (P<0.05) than that of liver treated with DMN alone respectively. The protein level of CuZn-SOD and activity of GSHPx in cultured rat hepatocytes treated with ferric nitrilotriacetate (FeNTA) plus 1×10-7 mol/L of idoxifene were 2. 3.43 times (P<0.05) and 2.52 times (P<0.05) greater than that treated with FeNTA alone. Idoxifene could inhibit HSC activation. Compared with the control, the uptake of BrdU in HSC cultured with 1×10-7 mol/L of idoxifene was reduced by 51.87 % (P<0.05), and the number of apoptotic HSCs cultured with 1×10-7 mol/L of idoxifene increased by 94.52% (P<0.05).
Conclusion:
Idoxifene showed inhibitory action on hepatic fibrosis in male rats.
Similar content being viewed by others
Article PDF
References
Yasuda M, Shimizu I, Shiba M, Ito S . Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 1999; 29: 719–27.
Shimizu I, Ma YR, Mizobuchi Y, Liu F, Miura T, Nakai Y, et al. Effects of Sho-saiko-to, a japanese herbal madicine, on hepatic fibrosis in rats. Hepatology 1999; 29: 149–60.
Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, et al. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Cancer Res 1999; 59: 3646–51.
Hirsimaki P, Aaltonen A, Mantyla E . Toxicity of antiestrogens. Breast J 2002; 8: 92–6.
Baumer AT, Wassmann S, Ahlbory K, Strehlow K, Muller C, Sauer H, et al. Reduction of oxidative stress and AT receptor expression by the selective oestrogen receptor modulator idoxifene. Br J Pharmacol 2001; 134: 579–84.
Omoya T, Shimizu I, Zhou Y, Okamura Y, Inoue H, Lu G, et al. Effects of idoxifene and estradiol on NF-kappaB activation in cultured rat hepatocytes undergoing oxidative stress. Liver 2001; 21: 183–91.
Poli G . Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000; 21: 49–98.
Friedman SL . Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247–50.
Alcolado R, Arthur MJ, Iredale JP . Pathogenesis of liver fibrosis. Clin Sci (Lond) 1997; 92: 103–12.
Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538–49.
Shimizu I, Ichihara A, Nakamura T . Hepatocyte growth factor in ascites from patiens with cirrhosis. J Biochem 1991; 109: 14–8.
Morel I, Lescoat G, Cillard J, Pasdeloup N, Brissot P, Cillard P . Kinetic evaluation of free malondialdehyde and enzyme leakage as indices of iron damage in rat hepatocyte cultures. Biochem Pharmacol 1990; 39: 1647–55.
Liu Y, Shimizu I, Omoya T, Ito S, Gu XS, Zuo J . Protective effects of estradiol on hepatocytic oxidative damage. World J Gastroenterol 2002; 8: 363–6.
Zhou YJ, Yin DM, Chen HS, Zhu HX, Wan X . Effects of blocking transforming growth factor signaling on culture-activated rat hepatic stellate cells. Chin J Hepatol 2003; 11: 282–4.
Lee KS, Buck M, Houglum K, Chojkier M . Activation of hepatic stellate cells by TGF α and collagen type I mediated by oxidative stress through c-myb expression. J Clin Invest 1995; 96: 2461–6.
Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colell A . Mitochondrial glutathione: importance and transport. Semin Liver Dis 1998; 18: 389–401.
Maher JJ . Leukocytes as modulators of stellate cell activation. Alcohol Clin Exp Res 1999; 23: 917–21.
Svegliati Baroni G, D'Ambrosio L, Ferretti G, Casini A, Di Sario A, Salzano R, et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998; 27: 720–6.
Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001; 121: 685–98.
Czaja MJ . Induction and regulation of hepatocyte apoptosis by oxidative stress. Antioxid Redox Signal 2002; 4: 759–67.
Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003; 112: 152–9.
Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, et al. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002; 123: 1323–30.
Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001; 276: 49077–82.
Zhou YJ, Chen HS, Sha BX . Antiapoptotic mechanisms of idoxifene on cultured rat hepatocytes undergoing oxidative stress. Chin Pharm J 2005; 40: 278–81.
Xu JW, Gong J, Chang XM, Luo JY, Dong L, Hao ZM, et al. Estrogen reduces CCl4-induced liver fibrosis in rats. World J Gastroenterol 2002; 8: 883–7.
Burger HG . Selective oestrogen receptor modulators. Horm Res 2000; 53 Suppl 3: 25–9.
Smith CL, O'Malley BW . Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004; 25: 45–71.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by fund from Ministry of Education of China (No 02KJB310003), Jiangsu Province of China (No 20002247) and Medical College, Nan Tong University.
Rights and permissions
About this article
Cite this article
Zhou, Yj., Yin, Dm., Chen, Hs. et al. Inhibitory effects of idoxifene on hepatic fibrosis in rats. Acta Pharmacol Sin 26, 581–586 (2005). https://doi.org/10.1111/j.1745-7254.2005.00082.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00082.x